Different Biological Activities of Histidine-Rich Peptides Are Favored by Variations in Their Design.
amphipathic helix
antibacterial activity
cell penetrating peptide
histidine
hydrophilic angle
luciferase
protein delivery
saporin
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
20 05 2021
20 05 2021
Historique:
received:
30
04
2021
revised:
14
05
2021
accepted:
17
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
1
7
2021
Statut:
epublish
Résumé
The protein transduction and antimicrobial activities of histidine-rich designer peptides were investigated as a function of their sequence and compared to gene transfection, lentivirus transduction and calcein release activities. In membrane environments, the peptides adopt helical conformations where the positioning of the histidine side chains defines a hydrophilic angle when viewed as helical wheel. The transfection of DNA correlates with calcein release in biophysical experiments, being best for small hydrophilic angles supporting a model where lysis of the endosomal membrane is the limiting factor. In contrast, antimicrobial activities show an inverse correlation suggesting that other interactions and mechanisms dominate within the bacterial system. Furthermore, other derivatives control the lentiviral transduction enhancement or the transport of proteins into the cells. Here, we tested the transport into human cell lines of luciferase (63 kDa) and the ribosome-inactivating toxin saporin (30 kDa). Notably, depending on the protein, different peptide sequences are required for the best results, suggesting that the interactions are manifold and complex. As such, designed LAH4 peptides assure a large panel of biological and biophysical activities whereby the optimal result can be tuned by the physico-chemical properties of the sequences.
Identifiants
pubmed: 34065185
pii: toxins13050363
doi: 10.3390/toxins13050363
pmc: PMC8160934
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Fluoresceins
0
Peptides
0
Histidine
4QD397987E
Luciferases
EC 1.13.12.-
Saporins
EC 3.2.2.22
fluorexon
V0YM2B16TS
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale de la Recherche
ID : MemPepSyn 14-CE34-0001-01, Biosupramol 17-CE18-0033-3, Naturalarsenal 19-AMRB-0004-02, LabEx Chemistry of Complex Systems 10-LABX-0026_CSC
Organisme : RTRA Frontier Research in Chemistry
ID : support
Organisme : Region Grand Est
ID : PhD position
Références
Mol Ther Nucleic Acids. 2013 May 07;2:e90
pubmed: 23653154
J Pept Sci. 2011 Feb;17(2):88-93
pubmed: 21234979
Molecules. 2020 Nov 20;25(22):
pubmed: 33233580
Biochemistry. 1995 May 16;34(19):6521-6
pubmed: 7538786
Biomaterials. 2014 Aug;35(24):6454-61
pubmed: 24831975
J Pept Sci. 2011 May;17(5):306-14
pubmed: 21360627
J Am Chem Soc. 2020 Mar 4;142(9):4349-4355
pubmed: 32049533
J Mol Med (Berl). 2007 Feb;85(2):191-201
pubmed: 17111132
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1564-8
pubmed: 12563034
FASEB J. 2006 Feb;20(2):320-2
pubmed: 16352649
J Membr Biol. 1997 Apr 1;156(3):197-211
pubmed: 9096062
Biophys J. 2010 Oct 20;99(8):2507-15
pubmed: 20959091
Toxins (Basel). 2011 Jun;3(6):697-720
pubmed: 22069735
Pharm Res. 2010 Jul;27(7):1426-36
pubmed: 20393870
Vaccine. 2012 Jan 17;30(4):784-93
pubmed: 22120194
Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8):183212
pubmed: 32057757
Adv Exp Med Biol. 2019;1117:3-6
pubmed: 30980349
J Biol Chem. 1993 Oct 15;268(29):22112-8
pubmed: 8408070
Eur Biophys J. 2014 Nov;43(10-11):499-507
pubmed: 25182242
Biophys J. 2017 Sep 19;113(6):1290-1300
pubmed: 28734478
Antimicrob Agents Chemother. 2006 Oct;50(10):3305-11
pubmed: 17005809
Biochim Biophys Acta. 2016 May;1858(5):936-46
pubmed: 26577273
Bioconjug Chem. 2019 Apr 17;30(4):1133-1139
pubmed: 30860823
Biochemistry. 1997 Oct 21;36(42):12869-80
pubmed: 9335545
Mol Ther Methods Clin Dev. 2014 Feb 19;1:12
pubmed: 26015948
Hum Gene Ther Methods. 2014 Feb;25(1):48-56
pubmed: 24152219
Science. 1999 Sep 3;285(5433):1569-72
pubmed: 10477521
J Biol Chem. 2016 Jan 29;291(5):2161-9
pubmed: 26668323
Angew Chem Int Ed Engl. 2015 Sep 1;54(36):10583-6
pubmed: 26230624
Clin Microbiol Infect. 2000 Sep;6(9):509-15
pubmed: 11168187
J Biol Chem. 1999 Oct 8;274(41):29115-21
pubmed: 10506166
J Biol Chem. 2009 Jan 2;284(1):119-133
pubmed: 18984589
Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-3
pubmed: 25521313
J Mol Biol. 1996 Nov 15;263(5):768-75
pubmed: 8947574
Nat Nanotechnol. 2013 Feb;8(2):130-6
pubmed: 23334171
J Pept Sci. 2008 Apr;14(4):488-95
pubmed: 18085719
ACS Omega. 2018 Aug 15;3(8):9182-9190
pubmed: 31459052
Curr Opin Pharmacol. 2019 Aug;47:133-140
pubmed: 31048179
Langmuir. 2014 Sep 2;30(34):10374-83
pubmed: 25105913
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19446-19454
pubmed: 32723829
Expert Opin Biol Ther. 2021 Mar;21(3):361-370
pubmed: 32938243
J Biomol NMR. 1991 Jul;1(2):167-73
pubmed: 1726781
Biochemistry. 2007 Oct 9;46(40):11253-62
pubmed: 17848098
Front Microbiol. 2020 Aug 27;11:1902
pubmed: 32982998
J Phys Chem B. 2015 Jul 30;119(30):9678-87
pubmed: 26134591
Biophys J. 2010 Jun 2;98(11):2544-53
pubmed: 20513398
Sci Rep. 2017 Dec 1;7(1):16718
pubmed: 29196622
J Pept Sci. 2017 Apr;23(4):320-328
pubmed: 28067008
Biomolecules. 2018 Apr 18;8(2):
pubmed: 29670065
J Virol Methods. 2013 May;189(2):375-8
pubmed: 23454800
Mol Pharm. 2019 Apr 1;16(4):1633-1647
pubmed: 30817164
Acta Biomater. 2017 Dec;64:259-268
pubmed: 29017974
Sci Rep. 2017 Aug 29;7(1):9585
pubmed: 28852016
Angew Chem Int Ed Engl. 2010 Mar 29;49(14):2552-5
pubmed: 20209539
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-53
pubmed: 3299384
Anal Bioanal Chem. 2013 Jul;405(19):6145-54
pubmed: 23732866
Biophys J. 2007 Dec 15;93(12):4289-99
pubmed: 17766347
Theranostics. 2019 May 18;9(11):3280-3292
pubmed: 31244954
Neuron. 1996 Feb;16(2):407-13
pubmed: 8789955
Mini Rev Med Chem. 2007 May;7(5):491-7
pubmed: 17504184
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6597-601
pubmed: 2671997
Biochimie. 2009 Jun;91(6):734-43
pubmed: 19455745